REDUCTION OF STRONTIUM-90 BONE CANCER BY ZIRCONIUM CITRATE.
D000086:Acetazolamide; D000818:Animals; D001859:Bone Neoplasms; D002614:Chelating Agents; D002951:Citrates; D019343:Citric Acid; D008660:Metabolism; D051379:Mice; D009369:Neoplasms; D009374:Neoplasms, Experimental; D009381:Neoplasms, Radiation-Induced; D012516:Osteosarcoma; D011833:Radiation Injuries, Experimental; D011837:Radiation-Protective Agents; D011874:Radiometry; D012106:Research; D013324:Strontium; D013325:Strontium Isotopes; D015040:Zirconium
D002614:Chelating Agents; D002951:Citrates; D011837:Radiation-Protective Agents; D013325:Strontium Isotopes; D019343:Citric Acid; D015040:Zirconium; D000086:Acetazolamide; D013324:Strontium
ACETAZOLAMIDE; BONE NEOPLASMS; CHELATING AGENTS; CITRATES; EXPERIMENTAL LAB STUDY; METABOLISM; MICE; NEOPLASMS, EXPERIMENTAL; NEOPLASMS, RADIATION-INDUCED; RADIATION INJURY, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RADIOMETRY; STRONTIUM ISOTOPES; ZIRCONIUM